Integration of circulating tumor DNA in biliary tract cancer: the emerging landscape.

Although the study did not reach statistical significance, there was a trend toward increased relapse risk with a relapse rate 37.5% (ctDNA absent) vs 66.67% (ctDNA present) [ 75 ].

also in 111,027 other papers